Mineralys Therapeutics, Inc. (MLYS)
26.62
-0.55
(-2.02%)
USD |
NASDAQ |
Apr 10, 16:00
26.62
0.00 (0.00%)
After-Hours: 20:00
Mineralys Therapeutics Shareholders Equity (Quarterly) : 646.69M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen, Inc. | 18.26B |
| Syndax Pharmaceuticals, Inc. | 64.63M |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| Immunic, Inc. | -6.673M |
| Cogent Biosciences, Inc. | 636.37M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 661.81M |
| Total Liabilities (Quarterly) | 15.11M |
| Current Ratio | 43.76 |